139 related articles for article (PubMed ID: 33240535)
1. Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe.
Mandiriri AM; Pascoe MJ; Shamu T; Lowe S
South Afr J HIV Med; 2020; 21(1):1123. PubMed ID: 33240535
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of screening tests for cervical pre-cancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia.
Taghavi K; Moono M; Mwanahamuntu M; Roumet M; Limacher A; Kapesa H; Madliwa T; Rutjes A; Basu P; Low N; Manasyan A; Bohlius J
medRxiv; 2023 Jun; ():. PubMed ID: 37398043
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
[TBL] [Abstract][Full Text] [Related]
4. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
Fitzpatrick MB; Dube Mandishora RS; Katzenstein DA; McCarty K; Weber J; Sahoo MK; Manasa J; Chirenje ZM; Pinsky BA
Int J Infect Dis; 2019 May; 82():21-29. PubMed ID: 30807869
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
6. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
Konopnicki D; Manigart Y; Gilles C; Barlow P; De Marchin J; Feoli F; Delforge M; Clumeck N; De Wit S
AIDS; 2016 Jan; 30(3):425-33. PubMed ID: 26765936
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda.
Nakalembe M; Makanga P; Mubiru F; Swanson M; Martin J; Huchko M
Infect Agent Cancer; 2019; 14():14. PubMed ID: 31114629
[TBL] [Abstract][Full Text] [Related]
8. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
[TBL] [Abstract][Full Text] [Related]
9. Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda.
Murangwa A; Desai KT; Gage JC; Murenzi G; Tuyisenge P; Kanyabwisha F; Musafili A; Kubwimana G; Mutesa L; Anastos K; Kim HY; Castle PE
Afr J Lab Med; 2022; 11(1):1827. PubMed ID: 36353194
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus infection in HIV-positive African women living in Europe.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Int AIDS Soc; 2013 Feb; 16(1):18023. PubMed ID: 23406965
[TBL] [Abstract][Full Text] [Related]
14. The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study.
Xiao T; Ou CQ; Yang J; Wang C; Yang M; Yu T; Shen L; Xu X; Xing H
JMIR Public Health Surveill; 2022 Dec; 8(12):e38628. PubMed ID: 36480259
[TBL] [Abstract][Full Text] [Related]
15. Interest of cytology combined with Xpert
Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.
Sinayobye Jd; Sklar M; Hoover DR; Shi Q; Dusingize JC; Cohen M; Mutimura E; Asiimwe-Kateera B; Castle PE; Strickler H; Anastos K
Infect Agent Cancer; 2014; 9():40. PubMed ID: 25926864
[TBL] [Abstract][Full Text] [Related]
17. Confronting the human papillomavirus-HIV intersection: Cervical cytology implications for Kenyan women living with HIV.
Kangethe JM; Gichuhi S; Odari E; Pintye J; Mutai K; Abdullahi L; Maiyo A; Mureithi MW
South Afr J HIV Med; 2023; 24(1):1508. PubMed ID: 37928501
[TBL] [Abstract][Full Text] [Related]
18. HIV associated high-risk HPV infection among Nigerian women.
Akarolo-Anthony SN; Al-Mujtaba M; Famooto AO; Dareng EO; Olaniyan OB; Offiong R; Wheeler CM; Adebamowo CA
BMC Infect Dis; 2013 Nov; 13():521. PubMed ID: 24192311
[TBL] [Abstract][Full Text] [Related]
19. Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women.
Adebamowo SN; Olawande O; Famooto A; Dareng EO; Offiong R; Adebamowo CA;
Front Public Health; 2017; 5():178. PubMed ID: 28785554
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
